Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore

Shilpa Medicare subsidiary settles Rs. 20.13 crore dispute with Sartorius for Rs. 9 crore

By: IPP Bureau

Last updated : June 25, 2026 9:30 am



The resolution significantly reduces a long-standing contingent liability from the company's books


Shilpa Medicare Limited has announced that its material subsidiary, Shilpa Biologicals Private Limited, has successfully resolved a commercial dispute with Sartorius Stedim India Private Limited.

The resolution, finalized before the Commercial Court in Bengaluru, significantly reduces a long-standing contingent liability from the company's books.

By settling at less than half of the original claim, the company has cleared a major legal hurdle that had been impacting its financial sentiment.

Shilpa Medicare Limited Shilpa Biologicals Private Limited Sartorius Stedim India Private Limited.

First Published : June 25, 2026 12:00 am